Every man over 30 should get a complete male hormone panel including total and free testosterone, estradiol, LH, FSH, PSA, CBC, CMP, and thyroid markers (TSH, T4). These tests identify hormonal imbalances, metabolic dysfunction, and cardiovascular risk factors that are often asymptomatic. Physician interpretation of results is required before initiating any treatment.
The majority of men over 30 have never had a complete hormone panel. They've had a basic annual physical — cholesterol, blood pressure, maybe a CBC — but not the targeted labs that reveal the hormonal and metabolic picture that actually governs how they feel and perform.
This is a gap. And it's fixable.
A complete male health lab panel takes a single blood draw and provides a comprehensive baseline for optimization. Here are the eight markers every man over 30 should know.
What it measures: The total amount of testosterone in the blood, including both bound and unbound fractions.
Normal range: 300–1,000 ng/dL (varies by lab)
Optimal range for performance: 600–900 ng/dL
Why it matters: Total testosterone is the primary diagnostic marker for hypogonadism. Below 300 ng/dL with clinical symptoms meets the threshold for TRT evaluation. Many men feel suboptimal at levels technically within "normal" range — this is why free testosterone is equally important.
What it measures: The fraction of testosterone not bound to sex hormone-binding globulin (SHBG) or albumin — the bioavailable, active fraction.
Normal range: 9–30 ng/dL (varies by age and lab)
Why it matters: Total testosterone can be misleadingly normal while free testosterone is low — particularly in men with elevated SHBG. Free testosterone is the more clinically relevant marker for symptoms of low T.
What it measures: The primary estrogen in men, produced via aromatase conversion of testosterone.
Optimal range: 20–30 pg/mL
Why it matters: Elevated estradiol in men suppresses testosterone production, causes water retention, reduces libido, and can cause gynecomastia. Elevated estradiol is common in men with excess body fat (adipose tissue contains aromatase). Monitoring estradiol is essential during TRT.
What they measure: Luteinizing hormone (LH) and follicle-stimulating hormone (FSH) are pituitary hormones that regulate testosterone and sperm production.
Why they matter: LH and FSH distinguish between primary hypogonadism (testicular failure — high LH/FSH, low T) and secondary hypogonadism (pituitary/hypothalamic dysfunction — low LH/FSH, low T). This distinction determines treatment approach.
What it measures: A protein produced by the prostate gland. Elevated PSA may indicate prostate inflammation, benign prostatic hyperplasia, or prostate cancer.
Baseline range: Under 4 ng/mL (age-dependent)
Why it matters: PSA is a required baseline before initiating TRT. Testosterone therapy does not cause prostate cancer, but it can stimulate growth of pre-existing prostate cancer. A baseline PSA and ongoing monitoring are standard of care.
What it measures: Red blood cells, white blood cells, platelets, hemoglobin, and hematocrit.
Why it matters: TRT increases red blood cell production (erythropoiesis). Elevated hematocrit (above 54%) increases blood viscosity and thrombosis risk. CBC monitoring is required during TRT — typically at 6–8 weeks and every 3–6 months thereafter.
What it measures: Glucose, electrolytes, kidney function (creatinine, BUN), and liver function (ALT, AST, alkaline phosphatase).
Why it matters: Metabolic health is foundational to hormonal optimization. Insulin resistance, impaired kidney function, and liver dysfunction all affect hormone metabolism and treatment safety.
What it measures: Thyroid-stimulating hormone (TSH) and free thyroxine (T4) — markers of thyroid function.
Why it matters: Hypothyroidism mimics many symptoms of low testosterone: fatigue, weight gain, cognitive fog, mood changes, and reduced libido. Thyroid dysfunction must be identified and addressed before attributing all symptoms to low T.
Standard lab reference ranges are designed to identify disease — not optimize performance. A man with a total testosterone of 305 ng/dL is technically "normal" but may feel significantly suboptimal. The table below distinguishes standard normal ranges from the ranges associated with optimal male performance.
| Marker | Normal Range | Optimal (Performance) |
| Total Testosterone | 300–1,000 ng/dL | 600–900 ng/dL |
| Free Testosterone | 9–30 ng/dL | 15–25 ng/dL |
| Estradiol (E2) | 10–40 pg/mL | 20–30 pg/mL |
| PSA | Under 4 ng/mL | Under 2 ng/mL (baseline) |
| Hematocrit | 38.3–48.6% | Under 50% on TRT |
| TSH | 0.4–4.0 mIU/L | 1.0–2.5 mIU/L |
Redline RX coordinates a complete male hormone panel as part of the intake process — at-home kit or local draw, no clinic visit required. A board-certified physician reviews all results and builds a protocol based on your specific numbers, symptoms, and goals.
Join the waitlist at getredlinerx.com to get your panel coordinated as part of the founding member intake process.
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. All treatments require evaluation and a valid prescription from a licensed, board-certified physician. Results may vary. These statements have not been evaluated by the FDA. Compounded medications are not FDA-approved and have not been reviewed for safety, effectiveness, or manufacturing quality by the FDA. Medically reviewed by Redline RX Medical Advisory Team — April 15, 2026.